Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
For Phase I, all participants who completed the OCC were included in analyses relevant for that phase ( n = 32)
No studies show that microdosing gives the same outcomes
Retatrutide is an investigational triple agonist (GLP-1/GIP/glucagon) that has shown even greater weight loss than tirzepatide in early trials (up to 24% body weight reduction)
I have a doctors letter and prescription information if needed. Provide documentation when requested, but dont volunteer excessive medical details
US$ 22.45
US$ 22.64
US$ 27.42
